Pradaxa User's $542K Jury Win Upheld, Despite 'Close Call'
A Connecticut judge on Wednesday rejected Boehringer Ingelheim Pharmaceuticals' bid to escape its first loss in several bellwether trials over its blood thinner Pradaxa, saying that despite it being "a close...To view the full article, register now.
Already a subscriber? Click here to view full article